Positive Phase 1 Clinical Data of MTX110 in DMG Brain Cancer Demonstrating Increased Survival Presented at ISPNO 2024
02 juil. 2024 08h30 HE
|
Biodexa Pharmaceuticals PLC
July 2, 2024 Biodexa Pharmaceuticals PLC Positive Phase 1 Clinical Data of MTX110 in DMG Brain Cancer Demonstrating Increased Survival Presented at ISPNO 2024 After Only Two Infusions and Two...
Midatech commences US clinical study of its investigational treatment for fatal childhood brain cancer
25 mai 2018 07h00 HE
|
Midatech Pharma Plc
25 May 2018 Midatech Pharma PLC(“Midatech”, “Company” or “Group”) Midatech commences US clinical study of its investigational treatment for fatal childhood brain cancer Midatech Pharma (AIM:...